A B S T R A C T Nitroglycerin (TNG) causes a prolonged dilatation of coronary collaterals. To demonstrate a functional significance of this dilatation we measured the effect of TNG on myocardial contractile force in dogs 2j-4 wk after the left anterior descending coronary artery (LAD) had been embolized in closed-chest animals. Development of collaterals was documented by angiography. Via a left thoracotomy the main left coronary artery (LCA) and LAD distal to the embolized plug were cannulated. Coronary flow and perfusion pressure were recorded. Contractile force was measured with gauges sutured to epicardial areas supplied by the left circumflex coronary artery (LCf) and occluded LAD. Coronary perfusion pressure in the LCA was gradually decreased until the contractile force recorded by the LAD gauge diminished while the LCf gauge was unaffected. Under these conditions, with coronary perfusion pressure held constant with the aid of a Starling resistance, TNG (18 ,g) injected into the LCA increased peripheral LAD pressure by 3-12 mm Hg and contractile force in the LAD region by 36% (range 20-90%), returning it to near-normal levels, while having minimal effect in the LCf area. These changes persisted for 5 min. When LCf and LAD areas were both ischemic, intracoronary TNG had minimal effect on peripheral LAD pressure and contractile force. Thus, TNG causes prolonged dilatation of coronary collaterals and presumed increased collateral flow with subsequent enhancement of myocardial contractile force in ischemic areas. This effect is seen only when ischemia is limited to an area supplied by the collaterals. When the whole heart is This study was presented in part at the 22nd Annual
A B S T R A C T Nitroglycerin (TNG) causes a prolonged dilatation of coronary collaterals. To demonstrate a functional significance of this dilatation we measured the effect of TNG on myocardial contractile force in dogs 2j-4 wk after the left anterior descending coronary artery (LAD) had been embolized in closed-chest animals. Development of collaterals was documented by angiography. Via a left thoracotomy the main left coronary artery (LCA) and LAD distal to the embolized plug were cannulated. Coronary flow and perfusion pressure were recorded. Contractile force was measured with gauges sutured to epicardial areas supplied by the left circumflex coronary artery (LCf) and occluded LAD. Coronary perfusion pressure in the LCA was gradually decreased until the contractile force recorded by the LAD gauge diminished while the LCf gauge was unaffected. Under these conditions, with coronary perfusion pressure held constant with the aid of a Starling resistance, TNG (18 ,g ) injected into the LCA increased peripheral LAD pressure by 3-12 mm Hg and contractile force in the LAD region by 36% (range 20-90%), returning it to near-normal levels, while having minimal effect in the LCf area. These changes persisted for 5 min. When LCf and LAD areas were both ischemic, intracoronary TNG had minimal effect on peripheral LAD pressure and contractile force. Thus, TNG causes prolonged dilatation of coronary collaterals and presumed increased collateral flow with subsequent enhancement of myocardial contractile force in ischemic areas. This effect is seen only when ischemia is limited to an area supplied by the collaterals. When the whole heart is INTRODUCTION Although nitroglycerin (TNG)1 has been used for more than a century for the relief of angina pectoris, its mode of action remains uncertain. There is little doubt that nitrites decrease coronary vascular resistance (1, 2) and augment coronary flow in normal man (3) (4) (5) . Furthermore, relaxation of coronary vascular smooth muscle has been documented in helical strips of coronary arteries (6) , models in intact dogs (7) , and even coronary arteries of man (7) . Despite these observations, the clinical efficacy of TNG has most often been attributed to its peripheral effects (8) resulting in diminished myocardial oxygen consumption (9) and restoration of oxygen balance in ischemic myocardium. The ability of TNG to increase flow in atherosclerotic vessels has been questioned. However, with refined techniques investigators have documented an early increase in coronary blood flow in patients with abnormal vessels that is later obscured by the peripheral hypotensive effect of TNG (5, 10) . A biphasic effect of TNG on coronary blood flow is supported by carefully controlled studies in animals (11) (12) (13) . Moreover, a direct dilatory effect of TNG on coronary collaterals in dog (14) and man (15) has been shown, although the significance of the direct coronary effects of TNG is undermined by the recent report that only intravenous and not intracoronary administration of TNG is effective in the relief of angina in man (5 (6.6 French) was embolized into the LAD with a coaxial catheter system introduced into a femoral artery. The catheter system consisted of an outer red Kifa catheter and an inner Teflon catheter extending beyond the end of the former and carrying a hollow, tapered Kifa plug. Once the catneter system was maneuvered into the LAD, the Kifa catheter was anchored while the inner catheter was withdrawn into the outer one, thus releasing the plug into the LAD. 1-3 days before the acute study all dogs had coronary angiograms demonstrating complete occlusion of the LAD at the level of the plug with retrograde filling of the distal vessel from numerous collaterals. All dogs had careful visual inspection of the infarcted area at the termination of the study. The hearts were serially sectioned from apex to base and the areas of necrosis and of normal myocardium were measured by planimetry from photographs of the sections. In the group of eight an average of 4+2% of the left ventricular cross-sectional area was seen to have been infarcted. Four of these had no detectable infarct.
On the day of study the dogs were anesthetized with pentobarbital (27.5 mg/kg). Additional amounts were administered as required to maintain prolonged anesthesia. A polyvinyl catheter was introduced into the thoracic aorta via a femoral artery for measurement of systemic pressure with a Statham transducer (Statham Instruments, Inc., Oxnard, Calif.). After endotracheal intubation and mechanical ventilation with an intermittent positive pressure respirator with 100% oxygen, a left thoracotomy was performed. Anticoagulation was produced by injection of 20,000 U of heparin and maintained by injection of 10,000 U every 1-2 h.
The experimental preparation is diagrammed in Fig. 1 . The main left coronary artery (LCA) was cannulated with a modified Gregg cannula introduced into the left subclavian artery. Blood from the root of the aorta entered a side hole in the double-lumen shaft of the cannula, passed through a loop, and then returned via the other lumen to the coronary artery. The loop contained an extracorporeal flow probe attached to a Biotronex 410 flowmeter (Biotronex Laboratory, Inc., Silver Spring, Md.), a side arm for measurement of coronary perfusion pressure with a Statham transducer, and an area for intracoronary drug injection. These preparations showed marked pressure-independent autoregulation of coronary blood flow: steady-state coronary resistance decreased when perfusion pressure was lowered from the control level (17) . Perfusion sured in two animals. One dog had a large infarct (16% of the left ventricular cross-sectional area). Consequently it was not possible to find enough viable yet ischemic myocardium from which to record changes in contractile force. One additional animal had a very small gradient from LCA to distal LAD (9 mm Hg), which made it impossible to cause the LAD region to be selectively ischemic by restricting LCA inflow (see below).
Three dogs with intact coronary circulations at the time of study were used as controls. The preparation was identical to that above except that the LAD was acutely ligated in its middle third and then cannulated distal to the ligature.
All drugs were given into the isolated coronary artery in doses that were too small to cause systemic effects. A solution of TNG was prepared by dissolving 0. In three chronically prepared animals the response of the LAD and LCf strain gauge arches to varying coronary perfusion was examined by gradually increasing and then decreasing the coronary flow with the Sigmamotor pump in steps of 10-15 ml/min. In all animals perfusion pressure was then gradually decreased in a stepwise fashion and the Starling resistance used to maintain a constant perfusion pressure. At each level TNG was injected into the LCA and the response of strain gauge arches, PCP, and coronary flow were recorded. Adenosine was similarly tested in three animals for its effect on contractile force and PCP. 15% . This response, however, is contrasted with that of the gauge in the ischemic area. The response was similarly unvarying during supernormal pressures and flows, but at pressures below the control level of 90 mm Hg the gauge response fell precipitously and at the lowest perfusion pressure of 43 mm Hg was markedly depressed to 32% of control. Although the absolute changes varied between animals, the responses were qualitatively similar. Therefore, by lowering coronary perfusion pressure it was possible to make the area of the LAD quite ischemic while preserving the contractile force in the region of the LCf.
RESULTS
To determine the effects of TNG, coronary perfusion pressure in the main LCA was decreased until there was a differential effect on the strain gauges. In Fig. 3 tractile force in the LAD area increased markedly by 90% of the pre-TNG level while the LCf strain gauge arch was not affected.
For the six animals studied, the effect of TNG was maximal when the initial coronary perfusion pressure was lowered by an average of 40 mm Hg. At this pressure the LCf strain gauge arch was depressed only 4+1% (SEM) whereas the LAD gauge was depressed by 29+4% (SEM) of control (Fig. 4) . This difference is highly significant (P < 0.001). The maximal enhancement of the contractile force developed by the myocardium in the LAD area compared to the stable level just before administration of TNG averaged 36% (range 20-90%). However, the LCf gauge barely responded (average increase 2%, range 0-4%). When the contractile force at the peak of TNG's effect is compared to the measurement at normal perfusion pressure, it is evident that TNG can transiently restore the contractile force in the ischemic LAD region to near-normal levels (average 4% below control). TNG always increased pressure in the LAD distal to the occlusion (average 7 mm Hg, range 3-12 mm Hg). The rise was gradual and the effect persisted for 21-8 min (average 5 min).
The response to TNG was shown to be highly dependent on the level of the coronary perfusion pressure. A representative record of this is reproduced in Fig. 5 and results for all animals are tabulated in Table I . At the control coronary perfusion pressure of 97 mm Hg (left panel, Fig. 5 ), neither the LAD nor LCf region was ischemic as indicated by failure of contractile force to increase when perfusion pressure was raised (see Fig. 2 In three animals intracoronary adenosine was administered and a representative record is reproduced (Fig. 6) .z 0 FIGURE 5 Effect of coronary perfusion pressure on the response of collaterals to intracoronary (IC) TNG. Whereas peripheral LAD pressure is increased after TNG administration at all but the lowest coronary perfusion pressures, LAD contractile force is augmented only at those pressures when both the myocardium is ischemic and coronary collaterals can be dilated, i.e., at intermediate perfusion pressures. Coronary flow increments after TNG administration that signify dilation of coronary arterioles become progressively less as perfusion pressure is lowered. With the initial increment of coronary flow, peripheral LAD pressure and contractile force transiently decrease, suggesting a coronary steal. However, arteriolar tone of the distal resistance vessels rapidly returns to control levels, signalling the end of the coronary steal and unmasking the longer time-course and effects of coronary collateral dilatation. In the middle panel a small rise in systemic pressure after TNG administration may reflect a transient increase in left ventricular contractility. However, this observation was not a consistent finding in these studies. (19) , obtained during intraoperative studies in man. With our experimental protocol, it is possible to make selected portions of the dog's left ventricular myocardium ischemic by varying coronary perfusion (Fig. 2) . As demonstrated in Fig. 5 Fig. 5 (pressure > B) , no area of the heart is ischemic. Under these conditions, TNG would not be expected to augment contractile force. Nevertheless, PCP is augmented by TNG. WAith a modest decrease of coronary perfusion pressure (A < pressure < B), corresponding to the middle panel in Fig. 5 , the area perfused by the LAD becomes ischemic, as witnessed by the decline in contractile force. TNG again increases PCP and flow, but in this situation also nearly restores the contractile force in the area of the LAD to the control level. As anticipated, the normal area of the LCf is un- (pressure < A), corresponding to the right panel in Fig. 5 , both LAD and LCf gauiges indicate regional ischemia. Now TNG is inieffective in alterinig either PCP or contractile force.
Our modlel of the corolnary collateral circulation relative to these findinigs is presentecl ini Figs. 8 (14, 21, (23) (24) (25) (26) , radioisotopic determination of collateral flow (15, 23, 24, (27) (28) (29) (30) , and microsphere determination of flow distribution (31 (5) , and therefore the special conditions of our protocol must not be overlooked. Collateral vessels in the dog heart are often epicardial, whereas these vessels tend to be intramural in man (38 (18) . Therefore coronary vasodilatation alone could be deleterious by initiating a steal. However, TNG's ability to dilate coronary collaterals for significantly longer intervals than the normal resistance vessels provides a unique way of furnishing increased collateral flow to nutritionally deprived myocardium.
The mode of action of TNG may depend on the pathological circumstance in which it is used. Thus, with prior major but incomplete obstruction of a large coronary artery, collaterals may be established. With subsequent completion of this obstruction and ensuing myocardial infarction, the response of the remaining collaterals to TNG may be beneficial. In the absence of prior collaterals or in situations where all major vessels are equally diseased, the effectiveness of TNG may reflect its ability to reduce venous return and systolic loading of the heart. Such differences may also exist in the setting of angina pectoris.
